New Federal Contractors — February 18, 2026

9 contracts worth $1.2B to Leidos, Softrams, Nimbus, Palmetto GBA signal stable multi-year cash flows in Medicare IT/support through 2029.

6 awards totaling $330M to CACI, WidePoint, Aretecsbd, RQ-AECOM for IT/security/construction provide revenue visibility to 2027+.

7 contracts ($1.8B) to Caltech/JPL for space R&D through 2028 reflect reliable funding but no direct equity exposure as nonprofit.

Axient, Sigmat ech, Softrams secure $270M+ via set-asides/competition, indicating path to larger primes or M&A.

Firm-fixed-price exposure in 12 contracts ($1B+ incl Caddell, Potomac Electric, RQ-AECOM) risks overruns amid long periods (4-9yrs).

Heavy subawards ($700M+ across deals, e.g. HII $151M, Axient $370M) dilute prime margins.

$1.5B options unexercised (35% of total value) dependent on fed budgets through 2031.

$1.5B+ in options across Leidos (HHS/GSA $300M+ potential), HII ($262M), IBM ($72M) for backlog expansion to 2031.

Health IT/admin (NAICS 5415xx) captures 30% of value; follow-ons likely in Medicare/CMS priorities.

Small/disadvantaged biz wins (Softrams $81M, Aretecsbd $63M) as M&A targets for primes.

HHS/CMS awards 12 contracts ($1.4B, 32% total) in IT/admin/remediation, underscoring fed healthcare spend resilience.

Caltech/NASA 7 awards ($1.8B, 41% total) via non-competed FFRDC model signal steady but nonprofit-capped funding.

80%+ extend 5+yrs (to 2034), with full obligations signaling committed spend.

{"entity"=>"Leidos (LDOS)", "reason"=>"2 awards $211M obligated, $165M options in HHS/GSA IT to 2031.", "trigger"=>"Option exercises >$100M"}

{"entity"=>"Caltech/JPL Ecosystem", "reason"=>"$1.8B concentration (41% total); tracks NASA budget health.", "trigger"=>"Outlay acceleration or cuts"}

{"entity"=>"Small Biz Primes (Softrams, Axient)", "reason"=>"$250M+ wins position for growth/M&A.", "trigger"=>"Follow-on non-setaside awards"}